Dominant negative mutant cyclin T1 proteins that inhibit HIV transcription by forming a kinase inactive complex with Tat

Journal of General Virology

Volumn 89, Issue 11, 2008, Pages 2783-2787

  Jadlowsky, Julie K ^a   Nojima, Masanori ^a   Okamoto, Takashi ^b   Fujinaga, Koh ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 9; CYCLIN T1; LENTIVIRUS VECTOR; MUTANT CYCLIN T1; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIVIRAL ACTIVITY; ARTICLE; DRUG SYNTHESIS; ENZYME INACTIVATION; GENE INTERACTION; GENE MUTATION; GENE OVEREXPRESSION; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS TRANSCRIPTION;

CYCLIN-DEPENDENT KINASE 9; CYCLINS; HIV; HUMANS; MODELS, MOLECULAR; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN CONFORMATION; PROTEIN SUBUNITS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 56349162167     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.2008/002857-0     Document Type: Article

References (32)

1. Anand, K., Schulte, A., Fujinaga, K., Scheffzek, K. & Geyer, M. (2007). Cyclin box structure of the P-TEFb subunit cyclin T1 derived from a fusion complex with EIAV tat. J Mol Biol 370, 826-836.
2. Bai, J., Sui, J., Zhu, R. Y., Tallarico, A. S., Gennari, F., Zhang, D. & Marasco, W. A. (2003). Inhibition of Tat-mediated transactivation and HIV-1 replication by human anti-hCyclinT1 intrabodies. J Biol Chem 278, 1433-1442.
3. Barboric, M., Yik, J. H., Czudnochowski, N., Yang, Z., Chen, R., Contreras, X., Geyer, M., Matija Peterlin, B. & Zhou, Q. (2007). Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription. Nucleic Acids Res 35, 2003-2012.
4. Bieniasz, P. D., Grdina, T. A., Bogerd, H. P. & Cullen, B. R. (1998). Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J 17, 7056-7065.
5. Bieniasz, P. D., Grdina, T. A., Bogerd, H. P. & Cullen, B. R. (1999). Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. Proc Natl Acad Sci U S A 96, 7791-7796.
6. Chao, S. H. & Price, D. H. (2001). Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo. J Biol Chem 276, 31793-31799.
7. Chao, S. H., Fujinaga, K., Marion, J. E., Taube, R., Sausville, E. A., Senderowicz, A. M., Peterlin, B. M. & Price, D. H. (2000). Flavopiridol inhibits P-TEFb and blocks HIV-1 replication. J Biol Chem 275, 28345-28348.
8. Dames, S. A., Schonichen, A., Schulte, A., Barboric, M., Peterlin, B. M., Grzesiek, S. & Geyer, M. (2007). Structure of the cyclin T binding domain of Hexim1 and molecular basis for its recognition of P-TEFb. Proc Natl Acad Sci U S A 104, 14312-14317.
9. Diehl, J. A. & Sherr, C. J. (1997). A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase. Mol Cell Biol 17, 7362-7374.
10. Fujinaga, K., Taube, R., Wimmer, J., Cujec, T. P. & Peterlin, B. M. (1999). Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. Proc Natl Acad Sci U S A 96, 1285-1290.
11. Fujinaga, K., Irwin, D., Geyer, M. & Peterlin, B. M. (2002). Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression. J Virol 76, 10873-10881.
12. Garber, M. E., Wei, P. & Jones, K. A. (1998a). HIV-1 Tat interacts with cyclin T1 to direct the P-TEFb CTD kinase complex to TAR RNA. Cold Spring Harb Symp Quant Biol 63, 371-380.
13. Garber, M. E., Wei, P., KewalRamani, V. N., Mayall, T. P., Herrmann, C. H., Rice, A. P., Littman, D. R. & Jones, K. A. (1998b). The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev 12, 3512-3527.
14. Heredia, A., Davis, C., Bamba, D., Le, N., Gwarzo, M. Y., Sadowska, M., Gallo, R. C. & Redfield, R. R. (2005). Indirubin-3′-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication. AIDS 19, 2087-2095.
15. Herrmann, C. H., Carroll, R. G., Wei, P., Jones, K. A. & Rice, A. P. (1998). Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines. J Virol 72, 9881-9888.
16. Hwang, S., Tamilarasu, N., Kibler, K., Cao, H., Ali, A., Ping, Y. H., Jeang, K. T. & Rana, T. M. (2003). Discovery of a small molecule Tat-trans-activation-responsive RNA antagonist that potently inhibits human immunodeficiency virus-1 replication. J Biol Chem 278, 39092-39103.
17. Ivanov, D., Kwak, Y. T., Nee, E., Guo, J., Garcia-Martinez, L. F. & Gaynor, R. B. (1999). Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation. J Mol Biol 288, 41-56.
18. Karn, J. (1999). Tackling Tat. J Mol Biol 293, 235-254.
19. Kim, Y. K., Bourgeois, C. F., Isel, C., Churcher, M. J. & Karn, J. (2002). Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation. Mol Cell Biol 22, 4622-4637.
20. Kim, Y. K., Bourgeois, C. F., Pearson, R., Tyagi, M., West, M. J., Wong, J., Wu, S. Y., Chiang, C. M. & Karn, J. (2006). Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency. EMBO J 25, 3596-3604.
21. Lind, K. E., Du, Z., Fujinaga, K., Peterlin, B. M. & James, T. L. (2002). Structure-based computational database screening, in vitro assay, andNMR assessment of compounds that target TAR RNA. Chem Biol 9, 185-193.
22. Mancebo, H. S., Lee, G., Flygare, J., Tomassini, J., Luu, P., Zhu, Y., Peng, J., Blau, C., Hazuda, D. & other authors (1997). P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev 11, 2633-2644.
23. Michels, A. A., Nguyen, V. T., Fraldi, A., Labas, V., Edwards, M., Bonnet, F., Lania, L. & Bensaude, O. (2003). MAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent manner. Mol Cell Biol 23, 4859-4869.
24. Mischiati, C., Jeang, K. T., Feriotto, G., Breda, L., Borgatti, M., Bianchi, N. & Gambari, R. (2001). Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA. Antisense Nucleic Acid Drug Dev 11, 209-217.
25. Napolitano, G., Mazzocco, A., Fraldi, A., Majello, B. & Lania, L. (2003). Functional inactivation of Cdk9 through oligomerization chain reaction. Oncogene 22, 4882-4888.
26. Nguyen, V. T., Kiss, T., Michels, A. A. & Bensaude, O. (2001). 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature 414, 322-325.
27. Okamoto, H., Cujec, T. P., Okamoto, M., Peterlin, B. M., Baba, M. & Okamoto, T. (2000). Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37. Virology 272, 402-408.
28. Peterlin, B. M. & Price, D. H. (2006). Controlling the elongation phase of transcription with P-TEFb. Mol Cell 23, 297-305.
29. Richter, S. N. & Palu, G. (2006). Inhibitors of HIV-1 Tat-mediated transactivation. Curr Med Chem 13, 1305-1315.
30. Schulte, A., Czudnochowski, N., Barboric, M., Schonichen, A., Blazek, D., Peterlin, B. M. & Geyer, M. (2005). Identification of a cyclin T-binding domain in Hexim1 and biochemical analysis of its binding competition with HIV-1 Tat. J Biol Chem 280, 24968-24977.
31. Taube, R., Fujinaga, K., Wimmer, J., Barboric, M. & Peterlin, B. M. (1999). Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation. Virology 264, 245-253.
32. Yang, Z., Zhu, Q., Luo, K. & Zhou, Q. (2001). The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription. Nature 414, 317-322.